Under construction – not a live service
Sign in

What researchers published on IgA nephropathy

834 papers, newest first.

Showing 80 of 834

  • Not labelled yetIptacopan in IgA Nephropathy - Final 24-Month Data.The New England journal of medicine
  • Not labelled yetIptacopan in IgA Nephropathy - Final 24-Month Data.The New England journal of medicine
  • Not labelled yetIptacopan in IgA Nephropathy - Final 24-Month Data. Reply.The New England journal of medicine
  • Not labelled yetIptacopan in IgA Nephropathy - Final 24-Month Data.The New England journal of medicine
  • Not labelled yetClinical significance of the systemic immune-inflammation index as a minimally invasive biomarker reflecting histological activity in IgA nephropathy.Renal failure
  • Not labelled yetCurrent status and optimization strategies for immunoglobulin a nephropathy management in the Western Region of Chongqing, China: A cross-sectional study.Medicine
  • Not labelled yetImpact of recurrent IgA nephropathy on long-term kidney transplant outcomes: a cohort comparison with autosomal dominant polycystic kidney disease.BMC nephrology
  • ReviewThe oral-kidney axis in IgA nephropathy: cnm-positive Streptococcus mutans as a microbial trigger.Clinical and experimental nephrology
  • Not labelled yetUp-regulation of CXCR3 on tonsillar T-cells in patients with IgA nephropathy.Clinical and experimental immunology
  • Not labelled yetPathogenic Gd-IgA1: Redefining the Role of Galactose-Deficient IgA1 in IgA Nephropathy.Journal of the American Society of Nephrology : JASN
  • Not labelled yetLongitudinal changes in proteinuria and kidney function during standard-dose Nefecon treatment in IgA nephropathy: A real-world cohort study.Clinical nephrology
  • Not labelled yetReview of the 10-year kidney biopsy experience of the Szeged Nephrology and Hypertension Center: a comparison of pre-biopsy clinical and biopsy-proven histological diagnoses.Renal failure
  • ReviewIgA nephropathy: evolving treatment strategies.Jornal brasileiro de nefrologia
  • Case reportCombined Rituximab and Daratumumab Induces Remission in Refractory Post-Transplant Crescentic IgA Nephropathy.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • Not labelled yetPerceptions and preferences of self-injectable therapies among adults living with immunoglobulin A nephropathy in the United States: a mixed-methods study.Current medical research and opinion
  • Not labelled yetSparsentan as First-Line Treatment in IgAN From SPARTAN.Kidney international reports
  • Not labelled yetRituximab in IgA Nephropathy: The RITA Multicenter Randomized Trial.American journal of kidney diseases : the official journal of the National Kidney Foundation
  • Case reportPulmonary-Cardiac Involvement in a Patient with IgA Vasculitis.Methodist DeBakey cardiovascular journal
  • PreprintMucosal Inflammation as a Driver of Gd-IgA1 Production in IgA Nephropathy: Mechanistic Support for Targeted Therapies.bioRxiv : the preprint server for biology
  • Not labelled yetTranscriptomic Identification of Candidate Biomarkers Associated With Vascular Calcification-Related Signaling Pathways in Immunoglobulin A Nephropathy.International journal of genomics
  • Not labelled yetSibeprenlimab in IgA nephropathy: does the fairy tale continue in phase 3?Annals of translational medicine
  • Case reportIgA nephropathy in a patient with 17α-hydroxylase/17,20-lyase deficiency caused by the CYP17A1 p. Y329fs mutation: a case report and review.BMC pediatrics
  • Not labelled yetIntegrated Transcriptomic Analysis and Experimental Validation Identify ATF3 as a Mesangial Cell-Associated Candidate Regulator in IgA Nephropathy.Journal of inflammation research
  • Not labelled yetPrognostic nutritional index is associated with clinical and histopathological severity in IgA nephropathy.Renal failure
  • Not labelled yetMulti-Omics Analysis Uncovers a Link Between Dysregulated Steroid Hormone Biosynthesis and Pediatric IgA Vasculitis Nephritis.Frontiers in bioscience (Landmark edition)
  • Not labelled yetAutomatic Ultrasound Habitat Radiomics for Differentiating Henoch-Schonlein Purpura Nephritis from IgA Nephropathy in Children: A Multicenter Study.Academic radiology
  • Not labelled yetTargeted-Release Budesonide in Chinese Patients with IgA Nephropathy: A Real-World Retrospective Cohort Study.Drug design, development and therapy
  • Not labelled yetAssociation of tonsillar Pseudomonas identified by 16S rRNA sequencing with clinical remission after tonsillectomy in IgA nephropathy: a machine learning approach.Clinical and experimental nephrology
  • Not labelled yetWhen red eyes signal glomerular disease: IgA nephropathy presenting as recurrent episcleritis and scleritis.Tropical doctor
  • Systematic reviewCrystalline κ-light-chain proximal tubulopathy in Waldenström macroglobulinemia with an IgA nephropathy pattern: a case report and systematic review.Frontiers in immunology
  • Not labelled yetLessons from IgA nephropathy: reevaluating the prognosis and management of class I and class II lupus nephritis.Renal failure
  • ReviewTreatment and practical considerations of IgA nephropathy.Frontiers in medicine
  • Not labelled yetPrognostic value of the neutrophil percentage-to-albumin ratio in patients with IgA nephropathy.BMC nephrology
  • Not labelled yetAssociation of the Red Blood Cell Distribution Width-to-Albumin Ratio with Renal Outcomes in Chinese Patients with IgA Nephropathy.Journal of clinical medicine
  • Not labelled yetDU-KAN: A Dual-Domain Enhanced Deep-Learning Framework for Digital Pathology-Based Oxford MEST-C Assessment in Pediatric IgA Nephropathy.Bioengineering (Basel, Switzerland)
  • ReviewChallenges in access to novel IgA nephropathy therapeutics in South Asia.The Lancet regional health. Southeast Asia
  • Not labelled yetSuccessful Tocilizumab Monotherapy for Steroid-Dependent TAFRO Syndrome with IgA Nephropathy.Turkish journal of haematology : official journal of Turkish Society of Haematology
  • Case reportPostpartum Triple Allograft Injury with Atypical Hemolytic Uremic Syndrome, Recurrent IgA Nephropathy, and Antibody-Mediated Rejection in a Kidney Retransplant Recipient: A Case Report.Journal of clinical medicine
  • Not labelled yetPregnancy Outcomes and Long-Term Kidney Function in Women with Primary Glomerulonephritis.Journal of nephrology
  • Not labelled yetCombined and simultaneous use of Nefecon and irbesartan in treatment-naïve primary IgA nephropathy: A retrospective study.Medicine
  • Not labelled yetHow I Do It: Recurrent IgA Nephropathy After Transplant-Integrating Emerging Therapies Into Practice.Transplantation
  • ReviewIgA nephropathy: evolving pathogenic concepts and emerging targeted therapies.Human immunology
  • Not labelled yetClinical characteristics and prognosis of IgA nephropathy with predominant light chain deposition.Renal failure
  • ReviewPrimary Mesangial Proliferative Glomerulonephritis: The Forgotten Glomerulopathy.Antibodies (Basel, Switzerland)
  • ReviewIgA nephropathy: gut microbiome insights and unmet needs in pediatrics.Pediatric nephrology (Berlin, Germany)
  • ReviewB-cell modulators in immunoglobulin A nephropathy.Frontiers in immunology
  • Not labelled yetLeast but not last: Durable C5 silencing for IgA nephropathy.Molecular therapy : the journal of the American Society of Gene Therapy
  • Not labelled yetPeritoneal M2 macrophage-derived extracellular vesicles as a nanotherapeutic for immune-oxidative microenvironment reprogramming in IgA nephropathy.Journal of materials chemistry. B
  • Not labelled yetRavulizumab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial.The New England journal of medicine
  • Not labelled yetLong-term efficacy and safety for the complement factor B inhibitor iptacopan in IgA nephropathy.Kidney international
  • Not labelled yetOutcomes Following Kidney Failure From IgA Nephropathy Compared to Diabetic Kidney Disease and Other Glomerular Diseases.American journal of kidney diseases : the official journal of the National Kidney Foundation
  • Not labelled yetAtacicept in IgA Nephropathy - Phase 3 Trial Final Efficacy Analysis.The New England journal of medicine
  • Not labelled yetKidney biopsy in the diagnosis of immunoglobulin A nephropathy.Frontiers in medicine
  • Not labelled yetUrinary Biomarker Analysis of the SANCTUARY Trial: Insights into IgA Nephropathy Pathophysiology and Ravulizumab Mechanism of Action.Clinical journal of the American Society of Nephrology : CJASN
  • Randomised trialInterim Analysis of a Phase 3 Trial of Povetacicept in IgA Nephropathy.The New England journal of medicine
  • Not labelled yetSibeprenlimab in IgA Nephropathy - Final Phase 3 Trial Analysis.The New England journal of medicine
  • Not labelled yetCharacterization of IgA, IgA immune complexes and complement depositions in IgA nephropathy using laser microdissection and mass spectrometry.Kidney international
  • Not labelled yetExosomal C3a initiates the NF-κB-dependent inflammatory axis in IgA nephropathy: a three-phase pilot study integrating clinical, in vivo, and in vitro evidence.Clinical and experimental nephrology
  • Not labelled yetGlomerulonephritis before and after BNT162b2 mRNA vaccine rollout: biopsy-based trends, histopathological spectrum, and temporal associations.International urology and nephrology
  • Not labelled yetSingle-cell transcriptomic analysis of the terminal ileum identifies BCMA as a therapeutic target in IgA nephropathy.hLife
  • Not labelled yet[Preliminary evaluation of the efficacy and safety of telitacicept in children with IgA nephropathy].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
  • Not labelled yetCorrection: Efficacy and safety of Nefecon, glucocorticoids, or supportive therapyadded to RASi+SGLT2i in IgA nephropathy.Frontiers in pharmacology
  • Not labelled yetCorticosteroids, serum proteins, and the next phase of precision medicine in IgA nephropathy.Clinical kidney journal
  • Not labelled yetIntegrating multiple omics approaches to identify AIF1 as a protective factor in IgA nephropathy.Journal of translational autoimmunity
  • Not labelled yetEfficacy and safety of low-dose telitacicept in IgA nephropathy: a real-world study.Clinical kidney journal
  • Review[IgA Nephropathy Update 2025/2026].Deutsche medizinische Wochenschrift (1946)
  • Not labelled yetSafety and efficacy of prednisolone, mizoribine and lisinopril combination therapy for severe childhood IgA nephropathy.Clinical and experimental nephrology
  • ReviewGd-IgA1-targeting therapy in IgA nephropathy ~what is pathogenic Gd-IgA1?~.Frontiers in nephrology
  • Systematic reviewMapping the complement-targeted landscape in igA nephropathy: a systematic review with structured descriptive synthesis.Frontiers in medicine
  • Not labelled yetGlomerular Properdin Deposition Suggests a Favorable Therapeutic Response to Tonsillectomy and Steroid Pulse Therapy in IgA Nephropathy.Cureus
  • Not labelled yetFrom therapeutic lag to clinical trials: the changing landscape of pediatric IgA nephropathy.Pediatric nephrology (Berlin, Germany)
  • ReviewFrom Susceptibility Loci to Therapeutic Targets: The Genetic Architecture of IgA Nephropathy.International journal of molecular sciences
  • Not labelled yetHigh Prevalence of Oxford MEST-C Lesions in Immunoglobulin A Nephropathy of Kidney Allografts: A Single-Center Study from Viet Nam.Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
  • Not labelled yetReal-World Effectiveness of Targeted-Release Budesonide in IgA Nephropathy with Near-Universal SGLT2 Inhibitor Use.American journal of nephrology
  • Not labelled yetMicroangiopathic lesions associated with poor immunosuppressive therapy response in IgA nephropathy.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • Not labelled yetMetabolic profiles of IgA nephropathy, membranous nephropathy, and diabetic nephropathy.Archives of medical science : AMS
  • ReviewMonoclonal antibodies associated IgA nephropathy or other nephropathies.Frontiers in pharmacology
  • Not labelled yetPrognostic utility of Oxford MEST-C classification for allograft failure in transplant IgA nephropathy: A systematic review and meta-analysis.Journal of nephrology
  • Case reportTriple Renal Pathology in a Patient With Myeloperoxidase-Associated Vasculitis, Diabetic Nephropathy, and Immunoglobulin A Nephropathy: A Case Report.Cureus
  • ReviewPotential Roles of Escherichia coli in IgA Nephropathy: Evidence, Mechanistic Hypotheses and Microbiota-Targeted Strategies.Microbial biotechnology